Invex Therapeutics Ltd
ASX:IXC

Watchlist Manager
Invex Therapeutics Ltd Logo
Invex Therapeutics Ltd
ASX:IXC
Watchlist
Price: 0.125 AUD 8.7% Market Closed
Market Cap: 9.4m AUD

Intrinsic Value

The intrinsic value of one IXC stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.125 AUD, Invex Therapeutics Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

IXC Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Invex Therapeutics Ltd

Intrinsic Value History
Dive into the past to invest in the future

IXC looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether IXC usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about IXC?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IXC valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Invex Therapeutics Ltd.

Explain Valuation
Compare IXC to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IXC?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Invex Therapeutics Ltd

Current Assets 5.5m
Cash & Short-Term Investments 5.4m
Receivables 92.8k
Current Liabilities 220.6k
Accounts Payable 220.6k
Efficiency

Free Cash Flow Analysis
Invex Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Invex Therapeutics Ltd

Revenue
461.5k AUD
Operating Expenses
-938.4k AUD
Operating Income
-476.9k AUD
Other Expenses
0 AUD
Net Income
-476.9k AUD
Fundamental Scores

IXC Profitability Score
Profitability Due Diligence

Invex Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Invex Therapeutics Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

IXC Solvency Score
Solvency Due Diligence

Invex Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Invex Therapeutics Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IXC Price Targets Summary
Invex Therapeutics Ltd

There are no price targets for IXC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IXC is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one IXC stock?

The intrinsic value of one IXC stock under the Base Case scenario is hidden AUD.

Is IXC stock undervalued or overvalued?

Compared to the current market price of 0.125 AUD, Invex Therapeutics Ltd is hidden .

Back to Top